back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-08-18 12:37 Tx date 2026-08-17 |
$AGN
Grey Matters Health Inc. |
Williams, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+45,000 vol |
142,480 | |
| Filed 2026-08-18 12:36 Tx date 2026-08-17 |
$AGN
Grey Matters Health Inc. |
Williams, Mark
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-45,000 vol |
0 | |
| Filed 2026-08-13 09:35 Tx date 2026-08-10 |
$AGN
Grey Matters Health Inc. |
Williams, Mark
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
56 - Grant of rights
|
+45,000 vol |
45,000 | |
| Filed 2026-07-16 14:01 Tx date 2026-06-05 |
$AGN
Grey Matters Health Inc. |
Williams, Mark
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$24,000
+60,000 vol $0.40 each |
60,000 | |
| Filed 2026-07-16 14:00 Tx date 2026-06-05 |
$AGN
Grey Matters Health Inc. |
Williams, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$24,000
+60,000 vol $0.40 each |
97,480 | |
| Filed 2026-07-16 13:59 Tx date 2026-04-21 |
$AGN
Grey Matters Health Inc. |
Williams, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-337,320 vol |
37,480 | |
| Filed 2026-07-16 13:58 Tx date 2025-03-20 |
$AGN
Grey Matters Health Inc. |
Williams, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+205,000 vol |
374,800 | |
| Filed 2026-07-16 13:57 Tx date 2025-03-20 |
$AGN
Grey Matters Health Inc. |
Williams, Mark
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-205,000 vol |
0 | |
| Filed 2026-07-16 13:56 Tx date 2025-03-06 |
$AGN
Grey Matters Health Inc. |
Williams, Mark
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
56 - Grant of rights
|
+205,000 vol |
205,000 | |
| Filed 2026-07-16 13:53 Tx date 2025-01-06 |
$AGN
Grey Matters Health Inc. |
Williams, Mark
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-27,000
-20,000 vol $1.35 each |
0 | |
| Filed 2026-07-16 13:52 Tx date 2025-01-06 |
$AGN
Grey Matters Health Inc. |
Williams, Mark
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-26,780
-26,000 vol $1.03 each |
20,000 | |
| Filed 2026-07-16 13:44 Tx date 2026-03-06 |
$AGN
Grey Matters Health Inc. |
Williams, Mark
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
56 - Grant of rights
|
+205,000 vol |
||
| Filed 2026-07-16 13:43 Tx date 2024-02-09 |
$AGN
Grey Matters Health Inc. |
Williams, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+125,000 vol |
169,800 | |
| Filed 2026-07-16 13:42 Tx date 2024-02-09 |
$AGN
Grey Matters Health Inc. |
Williams, Mark
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-125,000 vol |
0 | |
| Filed 2024-07-25 11:53 Tx date 2024-07-23 |
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.) |
Williams, Mark
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
1,100,000 | |
| Filed 2024-02-04 10:51 Tx date 2024-01-30 |
$AGN
Algernon Pharmaceuticals Inc. |
Williams, Mark
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
56 - Grant of rights
|
+125,000 vol |
125,000 | |
| Filed 2024-01-04 15:40 Tx date 2024-01-02 |
$AGN
Algernon Pharmaceuticals Inc. |
Williams, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+26,668 vol |
44,800 | |
| Filed 2024-01-04 15:39 Tx date 2024-01-02 |
$AGN
Algernon Pharmaceuticals Inc. |
Williams, Mark
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-26,668 vol |
0 | |
| Filed 2023-05-09 19:08 Tx date 2023-05-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Williams, Mark
4 - Director of Issuer
Direct Ownership
|
Rights
58 - Expiration of rights
|
-18,132 vol |
0 | |
| Filed 2023-04-17 21:58 Tx date 2023-04-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Williams, Mark
4 - Director of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+18,132 vol |
18,132 |